Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/24 17:15 | 5/8/24 | APLS | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | 3 | S.d | -11,383 | 52.43 | 0 | -217 | 1,116 | D | |||||||||||||||
4/2/24 16:06 | 4/1/24 | APLS | Health | Drug | Pharmaceutical Preparations | Sullivan Timothy Eugene | MA | O | CFO | 2 | S.d | -614 | 61.40 | 0 | -10 | 150 | D | |||||||||||||||
3/20/24 17:18 | 3/19/24 | APLS | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D | 1 | S | -1,068 | 57.18 | 0 | -19 | 338 | I | ||||||||||||||||
3/19/24 16:03 | 3/18/24 | APLS | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | 1 | S | -564 | 56.90 | 0 | -10 | 55 | D | |||||||||||||||
3/18/24 16:19 | 3/15/24 | APLS | Health | Drug | Pharmaceutical Preparations | Chopas James George | MA | O | VP,Chief | 1 | S | -10 | 56.46 | 0 | 0 | 0 | 39 | D | ||||||||||||||
3/14/24 16:17 | 3/13/24 | APLS | Health | Drug | Pharmaceutical Preparations | Nicholson Nur | MA | O | Chief Te | 1 | S | -646 | 57.56 | 0 | -11 | 56 | D | |||||||||||||||
3/5/24 16:07 | 3/1/24 | APLS | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | 1 | S.d | -16,029 | 64.11 | 0 | -250 | 2,035 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |